90 related articles for article (PubMed ID: 10900653)
1. [Erythropoietin drugs in patients with chronic renal failure at the stage of conservative treatment. Effectiveness and side effects].
Alekseeva TB; Nikolaev AIu; Dasaeva LA
Ter Arkh; 2000; 72(6):58-60. PubMed ID: 10900653
[TBL] [Abstract][Full Text] [Related]
2. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
[TBL] [Abstract][Full Text] [Related]
3. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
4. [Case of early pronounced anemia and its effective treatment with human recombinant erythropoietin in a female patient with polycystic kidney in a conservative stage of chronic renal failure].
Alekseeva TB; Nikolaev AIu; Trofimova EI
Ter Arkh; 1999; 71(6):70-1. PubMed ID: 10420463
[No Abstract] [Full Text] [Related]
5. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
6. r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline.
Tapolyai M; Kadomatsu S; Perera-Chong M
BMC Nephrol; 2003 Jun; 4():3. PubMed ID: 12809563
[TBL] [Abstract][Full Text] [Related]
7. Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease.
Dean BB; Dylan M; Gano A; Knight K; Ofman JJ; Levine BS
Curr Med Res Opin; 2005 Jul; 21(7):981-7. PubMed ID: 16004664
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S
Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282
[TBL] [Abstract][Full Text] [Related]
9. [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency].
Kutyrina IM; Lifshits NL; Rogov VA; Kamyshova ES; Shvetsov MIu; Okonova EB; Androsova SO; Martynov SA; Miroshnichenko NG; Gerasimenko OI
Ter Arkh; 2002; 74(6):34-9. PubMed ID: 12136480
[TBL] [Abstract][Full Text] [Related]
10. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
11. Anaemia, iron studies and erythropoietin in patients of chronic renal failure.
Singh NP; Aggarwal L; Singh T; Anuradha S; Kohli R
J Assoc Physicians India; 1999 Mar; 47(3):284-90. PubMed ID: 10999121
[TBL] [Abstract][Full Text] [Related]
12. Do hemodialysis patients need higher doses of erythropoietin if given intravenously rather than subcutaneously?
McMahon LP
Nat Clin Pract Nephrol; 2006 May; 2(5):246-7. PubMed ID: 16932434
[No Abstract] [Full Text] [Related]
13. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
Giverhaug T; Falck A; Eriksen BO
J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
[TBL] [Abstract][Full Text] [Related]
14. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
15. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
Singh NP; Chandrashekhar ; Nair M; Anuradha S; Kohli R; Agarwal SK
J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
[TBL] [Abstract][Full Text] [Related]
16. Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study.
Teplan V; Schück O; Knotek A; Hajný J; Horácková M; Kvapil M;
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S26-30. PubMed ID: 12612947
[TBL] [Abstract][Full Text] [Related]
17. [Anemia syndrome in patients with chronic renal insufficiency on peritoneal dialysis treated with recombinant erythropoietin].
Romanova LA; Lugovskaia SA; Khareb F; Shumov EV; Shmarov DA
Urologiia; 2002; (5):26-30. PubMed ID: 12402772
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial.
Teplan V; Schück O; Votruba M; Poledne R; Kazdová L; Skibová J; Malý J
Wien Klin Wochenschr; 2001 Sep; 113(17-18):661-9. PubMed ID: 11603100
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin dose requirements when converting from subcutaneous to intravenous administration among patients on hemodialysis.
Moist LM; Muirhead N; Wazny LD; Gallo KL; Heidenheim AP; House AA
Ann Pharmacother; 2006 Feb; 40(2):198-203. PubMed ID: 16449549
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
